407 related articles for article (PubMed ID: 37492224)
121. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
122. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
123. Signaling pathways governing breast cancer stem cells behavior.
Song K; Farzaneh M
Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
[TBL] [Abstract][Full Text] [Related]
124. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
Front Oncol; 2020; 10():452. PubMed ID: 32426267
[TBL] [Abstract][Full Text] [Related]
125. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Saeg F; Anbalagan M
Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
[TBL] [Abstract][Full Text] [Related]
126. Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Nigam A
Indian J Surg; 2013 Jun; 75(3):170-80. PubMed ID: 24426422
[TBL] [Abstract][Full Text] [Related]
127. Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition.
Kundu P; Shankar BS
Biochim Biophys Acta Gen Subj; 2022 Nov; 1866(11):130215. PubMed ID: 35905921
[TBL] [Abstract][Full Text] [Related]
128. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
[TBL] [Abstract][Full Text] [Related]
129. A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progression.
Yan X; He Y; Yang S; Zeng T; Hua Y; Bao S; Yang F; Duan N; Sun C; Liang Y; Fu Z; Huang X; Li W; Yin Y
Cell Death Discov; 2022 Apr; 8(1):196. PubMed ID: 35413945
[TBL] [Abstract][Full Text] [Related]
130. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
Choi J; Park J; Cho I; Sheen Y
Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
[TBL] [Abstract][Full Text] [Related]
131. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition.
Tsubakihara Y; Ohata Y; Okita Y; Younis S; Eriksson J; Sellin ME; Ren J; Ten Dijke P; Miyazono K; Hikita A; Imamura T; Kato M; Heldin CH; Moustakas A
Mol Oncol; 2022 Jun; 16(12):2330-2354. PubMed ID: 35348275
[TBL] [Abstract][Full Text] [Related]
132. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling.
Rong Z; Zhang L; Li Z; Xiao Z; Duan Y; Ren X; Zi Y; Gao J; Mu Y; Guan Y; Cao Z; Wang X; Pei Q; Zeng Y; Fan Q; Zeng Z; Ou D; He J; Nie Y; Tan R; Weng L; Li Y; Xiang R; Deng Y; Sun L
Oncogene; 2022 Apr; 41(16):2390-2403. PubMed ID: 35277657
[TBL] [Abstract][Full Text] [Related]
133. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
[TBL] [Abstract][Full Text] [Related]
134. Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC.
Sulaiman A; McGarry S; Chilumula SC; Kandunuri R; Vinod V
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680503
[TBL] [Abstract][Full Text] [Related]
135. The role of R-spondin proteins in cancer biology.
Ter Steege EJ; Bakker ERM
Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
[TBL] [Abstract][Full Text] [Related]
136. Role of TGF-β signaling in the mechanisms of tamoxifen resistance.
Babyshkina N; Dronova T; Erdyneeva D; Gervas P; Cherdyntseva N
Cytokine Growth Factor Rev; 2021 Dec; 62():62-69. PubMed ID: 34635390
[TBL] [Abstract][Full Text] [Related]
137. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
Ko YC; Choi HS; Liu R; Lee DS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
[TBL] [Abstract][Full Text] [Related]
138. Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer.
Abreu de Oliveira WA; Moens S; El Laithy Y; van der Veer BK; Athanasouli P; Cortesi EE; Baietti MF; Koh KP; Ventura JJ; Amant F; Annibali D; Lluis F
Front Oncol; 2021; 11():705384. PubMed ID: 34367990
[TBL] [Abstract][Full Text] [Related]
139. ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling.
Zhu T; Zheng J; Zhuo W; Pan P; Li M; Zhang W; Zhou H; Gao Y; Li X; Liu Z
Cell Death Discov; 2021 May; 7(1):126. PubMed ID: 34052833
[TBL] [Abstract][Full Text] [Related]
140. Cancer stem cell characteristics and their potential as therapeutic targets.
Lim JR; Mouawad J; Gorton OK; Bubb WA; Kwan AH
Med Oncol; 2021 May; 38(7):76. PubMed ID: 34050825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
